RecruitingPhase 2NCT06568198
Modulation Effect of tACS on Chronic Low Back Pain
Modulation Effect of Transcranial Alternating Current Stimulation (tACS) on Chronic Low Back Pain
Sponsor
Massachusetts General Hospital
Enrollment
80 participants
Start Date
Aug 25, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
Investigating the modulation effect of tACS
Eligibility
Min Age: 18 YearsMax Age: 60 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a medical device called Real tACS and a medical device called Sham tACS for people with chronic low-back pain. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 60 Years.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEReal tACS
α-tACS at a frequency of alpha band at S1
DEVICESham tACS
Sham tACS with no stimulation applied
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06568198
Related Trials
"Lumbar Operatively Inserted PerQdisc Artificial Implant Following Nulcectomy" (LOPAIN2)
NCT0550836010 locations
Intracept Minimally-invasive PROcedure for VErtebrogenic Back Pain
NCT0682726217 locations
Detection of EEG-Based Biomarkers of Chronic Low Back Pain
NCT060252011 location
Managing Pain Using Optimized Sequences by Adjusting Parameters With Independent Current Control
NCT071908077 locations
Effectiveness of Thoracolumbar Fascia Mobilization and Ultrasound-Guided 5% Dextrose Injection in Chronic Low Back Pain
NCT072415591 location